 (RepresentativeDrugs-beta blocker)  Entity.USER  Entity.USER(          ) (=>          ) (X           )       (          ) 
            Out of PINDOLOL, LABETALOL HCL IN DEXTROSE, ZIAC, BETOPTIC S, CARVEDILOL PHOSPHATE, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC, INDERAL XL, TIMOLOL MALEATE OPHTHALMIC GEL 
FORMING, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.5%, COSOPT, TIMOPTIC-XE, TIMOLOL MALEATE, BRIMONIDINE TARTRATE, TIMOLOL MALEATE, ESMOLOL 
HYDROCHLORIDE IN SODIUM CHLORIDE, COSOPT PF, INNOPRAN XL, NEBIVOLOL, TIMOLOL MALEATE OPHTHALMIC, LEVOBUNOLOL HYDROCHLORIDE, ACEBUTOLOL HYDROCHLORIDE, PROPRANOLOL, DORZOLAMIDE AND TIMOLOL, METOPROLOL 
SUCCINATE, INDERAL, METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE, PROPRANOLOL HYDROCHLORIDE ER, CORGARD, BREVIBLOC, LABETALOL HCL IN SODIUM CHLORIDE, PROPRANOLOL HCL ER, COREG CR, LOPRESSOR HCT, 
METOPROLOL TARTRATE, BETAXOLOL HYDROCHLORIDE, METOPROLOL, METOROPROLOL TARTRATE, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, BRIMONIDINE TARTRATE AND TIMOLOL MALEATE, BYSTOLIC, ISTALOL, COREG, 
DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE, ESMOLOL HYDROCHLORIDE IN WATER, ATENOLOL AND CHLORTHALIDONE, HEMANGEOL, PROPRANOLOL HYDROCHLORIDE, COMBIGAN, DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE 
PRESERVATIVE FREE, CARVEDILOL, TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, TOPROL, ATENOLOL AND CHLORTHALIDONE TABLET, BISOPROLOL, BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION, 
DORZOLAMIDE HYDROCHLORIDE TIMOLOL MALETAE, BISOPROLOL FUMARATE, NADOLOL, METOPROLOL SUCCINATE ER, LABETALOL HCL, KAPSPARGO, TIMOLOL, BETIMOL, TIMOPTIC IN OCUDOSE, ATENOLOL, BRIMONIDINE 
TARTRATE/TIMOLOL MALEATE, BETAXOLOL, TENORMIN, ESMOLOL HYDROCHLORIDE, TOPROL XL, NEBIBOLOL, TIMOPTIC, TENORETIC, METOPROLOL SUCCINATE ER TABLETS, LABETALOL, TIMOLOL MALEATE OPHTHALMIC GEL FORMING 
SOLUTION, 0.25%, TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION 0.25%, NEBIVOLOL HYDROCHLORIDE, TIMOLOL MALEATE OPHTHALMIC GEL FORMING SOLUTION, 0.5%, LABETALOL HYDROCHLORIDE, INDERAL LA, DORZOLAMIDE
HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION, DDORZOLAMIDE HYDROCHLORIDE TIMOLOL MALEATE, LOPRESSOR, CARTEOLOL HYDROCHLORIDE, and TIMOLOL GFS, which three are the most common?

            The result of a query on a medical database is below:
            [('Metoprolol Tartrate', 241533), ('Metoprolol Succinate XL', 60543), ('Labetalol', 40134), ('Atenolol', 25351), ('Carvedilol', 23525), ('Nadolol', 6559), ('Metoprolol', 6514), 
('Propranolol', 5022), ('CARVedilol', 4259), ('Timolol Maleate 0.5%', 4119), ('Dorzolamide 2%/Timolol 0.5% Ophth.', 3305), ('Propranolol LA', 1199), ('Timolol Maleate 0.25%', 1094), ('Metoprolol XL 
(Toprol XL)', 933), ('Betaxolol Ophth Susp  0.25%', 236), ('bisoprolol fumarate', 163), ('Combigan', 132), ('Pindolol', 129), ('Propranolol HCl', 122), ('Bisoprolol Fumarate', 78), ('nebivolol', 72), 
('Bystolic', 66), ('Betaxolol', 50), ('brimonidine-timolol', 25), ('Metoprolol Tart 5mg/5mL 5mL VIAL', 25), ('timolol', 24), ('Labetalol 100mg/20mL 20mL VIAL', 18), ('timolol maleate', 17), 
('dorzolamide-timolol', 16), ('Cosopt', 15), ('Timoptic-XE', 11), ('Toprol XL', 10), ('dorzolamide-timolol (PF)', 10), ('Metoprolol ', 10), ('betaxolol', 8), ('Tenormin', 7), ('nadolol', 6), 
('carvedilol phosphate', 6), ('Istalol', 5), ('bisoprolol-hydrochlorothiazide', 5), ('Bystolic (nebivolol)', 5), ('Combigan (brimonidine-timolol)', 5), ('Inderal LA', 5), ('Timolol', 5), 
('Brimonidine-Timolol', 4), ('bisoprolol', 4), ('atenolol', 4), ('timolol maleate (PF)', 4), ('metoprolol tartrate', 4), ('Coreg CR', 4), ('Betoptic S', 3), ('Dorzolamide-Timolol', 3), ('propranolol',
3), ('Combigan 0.2%/0.5%', 3), ('Coreg', 3), ('Timoptic', 3), ('Propranolol 20mg Tab', 2), ('Timoptic 0.5% PF', 2), ('metoprolol succinate', 2), ('bisoprolol fumarate 10mg ', 2), ('Timolol ', 2), 
('Metoprolol Succinate', 2), ('meTOPROLOL succinate', 2), ('Timolol Maleate', 2), ('Cosopt (PF)', 2), ('Nebivolol', 2), ('Metoprolo', 2), ('carvediloL phosphate', 2), ('nebivolol (Bystolic)', 1), 
('Nebivolol (Bystolic)', 1), ('pindolol', 1), ('Combigan ', 1), ('brimonidine-timolol 0.2-0.5%', 1), ('Brimondine/timolol', 1), ('Ziac', 1), ('timolol 0.5%', 1), ('Timolol  0.5% Gel Forming Sol', 1), 
('Betimol', 1), ('Timolol Maleate 0.5% gel', 1), ('Timolol Maleate 0.5% GFS', 1), ('timolol maleate gel', 1), ('timolol maleate gel - PMTO', 1), ('timoptic', 1), ('Betaxolol HCl  0.25%', 1), 
('Timoptic-XE(Timolol maleate-XE)', 1), ('toprol', 1), ('Coreg CR  (Carvedilol)', 1), ('Combigan  0.2%/0.5%', 1), ('Cosopt PF', 1), ('Combigan Ophthalmic', 1), ('Dorzolamide-timolol', 1), 
('dorzolamide-timolol 22.3%-6.8%', 1), ('dorzolamide-timolol 22.3-6.8 mg/mL ', 1), ('dorzolamide-timolol 22.3/6.8mg/ml', 1), ('Combigan  drops  0.2 %/0.5%', 1), ('Atenolol oral suspension', 1), 
('Istalol 0.5%', 1), ('laBETalol', 1), ('Combigan drops', 1), ('Combigan (Brimonidine-Timolol)', 1), ('Metoprol', 1), ('metoprolol', 1), ('Combigan(brimonidine-timolol)', 1), ('Combigan 
(brimonidine/timolol)', 1), ('Combigan (brimonidine 0.2%/timolol 0.5%)                       ', 1), ('Combigan 0.2%-0.5% eye drops', 1), ('Metoprolol Tartra 12.5mg HALFTAB', 1), ('Combigan 0.2-0.5%', 
1), ('Metoprolol Tartrate Suspension', 1), ('Combigan 0.2%- 0.5% ', 1), ('Combigan (0.2-0.5%)', 1)]
            
 (RepresentativeDrugs-beta blocker)  Entity.USER  Entity.USER(Entity.USER) (=>          ) (X           )       (          ) [CANNOT RESPOND]
 (RepresentativeDrugs-beta blocker)  Entity.AGENT 
*(RepresentativeDrugs-beta blocker)  Entity.LLM  Entity.LLM(          ) (=>          ) (X           )   FUNC(final_answer) FUNC: {
  "name": "final_answer",
  "to": "",
  "arguments": {
    "question": "Which three beta blocker drugs from the provided list are the most common based on the usage rates from the medical database query?",
    "steps": [
      "Identify the drugs from the provided list that are beta blockers.",
      "Match the generic names of beta blockers from the list with their usage rates in the medical database query.",
      "Select the three beta blockers with the highest usage rates, ensuring they are different active ingredients and not derivatives of the same base drug.",
      "If the same drug appears multiple times with different formulations or combinations, consider the total prescription rate for that active ingredient."
    ],
    "answer": "METOPROLOL TARTRATE, LABETALOL, ATENOLOL",
    "request": "final_answer"
  }
}
*(RepresentativeDrugs-beta blocker)  Entity.LLM  Entity.AGENT(final_answer) (=>          ) (X           )       (          ) __PASS__:Critic
 (RepresentativeDrugs-beta blocker)  Entity.AGENT  Entity.AGENT(Entity.AGENT) (=>    Critic) (X           )       (          ) [CANNOT RESPOND]
 (RepresentativeDrugs-beta blocker)  Entity.LLM  Entity.LLM(Entity.LLM) (=>    Critic) (X           )       (          ) [CANNOT RESPOND]
 (Critic)  Entity.USER  Entity.USER(          ) (=>    Critic) (X           )   FUNC(final_answer) FUNC: {
  "name": "final_answer",
  "to": "",
  "arguments": {
    "question": "Which three beta blocker drugs from the provided list are the most common based on the usage rates from the medical database query?",
    "steps": [
      "Identify the drugs from the provided list that are beta blockers.",
      "Match the generic names of beta blockers from the list with their usage rates in the medical database query.",
      "Select the three beta blockers with the highest usage rates, ensuring they are different active ingredients and not derivatives of the same base drug.",
      "If the same drug appears multiple times with different formulations or combinations, consider the total prescription rate for that active ingredient."
    ],
    "answer": "METOPROLOL TARTRATE, LABETALOL, ATENOLOL",
    "request": "final_answer"
  }
}
*(Critic)  Entity.AGENT  Entity.AGENT(final_answer) (=>          ) (X           )       (          ) 
        Question: Which three beta blocker drugs from the provided list are the most common based on the usage rates from the medical database query?
        -----
        Reasoning:
        1. Identify the drugs from the provided list that are beta blockers.
2. Match the generic names of beta blockers from the list with their usage rates in the medical database query.
3. Select the three beta blockers with the highest usage rates, ensuring they are different active ingredients and not derivatives of the same base drug.
4. If the same drug appears multiple times with different formulations or combinations, consider the total prescription rate for that active ingredient.
        -----
        Final answer: METOPROLOL TARTRATE, LABETALOL, ATENOLOL
        
 (Critic)  Entity.USER 
 (Critic)  Entity.AGENT  Entity.AGENT(Entity.AGENT) (=>          ) (X           )       (          ) [CANNOT RESPOND]
*(Critic)  Entity.LLM  Entity.LLM(          ) (=>          ) (X           )   FUNC(  feedback) FUNC: {
  "name": "feedback",
  "to": "",
  "arguments": {
    "critique": "The reasoning process outlined is sound. It correctly identifies the steps needed to determine the most common beta blocker drugs based on usage rates: identifying beta blockers from 
a list, matching them with usage rates, selecting the top three with distinct active ingredients, and considering total prescription rates for the same active ingredient in different formulations. 
Without specific data to analyze, I cannot critique the accuracy of the final answer, but the reasoning itself does not contain any logical flaws.",
    "request": "feedback"
  }
}
*(Critic)  Entity.LLM  Entity.AGENT(  feedback) (=>          ) (X           )       (          ) <DONE> __PASS__
*(RepresentativeDrugs-beta blocker)  Critic  Entity.USER(    Critic) (=>          ) (X           )   FUNC(  feedback) FUNC: {
  "name": "feedback",
  "to": "",
  "arguments": {
    "critique": "The reasoning process outlined is sound. It correctly identifies the steps needed to determine the most common beta blocker drugs based on usage rates: identifying beta blockers from 
a list, matching them with usage rates, selecting the top three with distinct active ingredients, and considering total prescription rates for the same active ingredient in different formulations. 
Without specific data to analyze, I cannot critique the accuracy of the final answer, but the reasoning itself does not contain any logical flaws.",
    "request": "feedback"
  }
}
*(RepresentativeDrugs-beta blocker)  Entity.AGENT  Entity.AGENT(  feedback) (=>          ) (X           )       (          ) 
        Feedback: The reasoning process outlined is sound. It correctly identifies the steps needed to determine the most common beta blocker drugs based on usage rates: identifying beta blockers from
a list, matching them with usage rates, selecting the top three with distinct active ingredients, and considering total prescription rates for the same active ingredient in different formulations. 
Without specific data to analyze, I cannot critique the accuracy of the final answer, but the reasoning itself does not contain any logical flaws.

        If any flaws in the reasoning used to produce your
        answer were identified, you must try again.
        
 (RepresentativeDrugs-beta blocker)  Entity.USER 
 (RepresentativeDrugs-beta blocker)  Entity.AGENT  Entity.AGENT(Entity.AGENT) (=>          ) (X           )       (          ) [CANNOT RESPOND]
*(RepresentativeDrugs-beta blocker)  Entity.LLM  Entity.LLM(          ) (=>          ) (X           )   FUNC(submit_answer) FUNC: {
  "name": "submit_answer",
  "to": "",
  "arguments": {
    "representative_drugs": [
      "METOPROLOL TARTRATE",
      "LABETALOL",
      "ATENOLOL"
    ],
    "justification": "The three most common beta blocker drugs from the provided list, based on the usage rates from the medical database query, are METOPROLOL TARTRATE, LABETALOL, and ATENOLOL. These
drugs were selected because they are beta blockers with the highest usage rates according to the query results, and each represents a different active ingredient. METOPROLOL TARTRATE has the highest 
usage rate (241533), followed by LABETALOL (40134), and ATENOLOL (25351).",
    "request": "submit_answer"
  }
}
*(RepresentativeDrugs-beta blocker)  Entity.AGENT  Entity.AGENT(submit_answer) (=>          ) (X           )       (          ) <DONE>
